Suppr超能文献

使用长效可逆避孕法的女性的身体成分变化。

Changes in body composition in women using long-acting reversible contraception.

作者信息

Silva Dos Santos Priscilla de Nazaré, Madden Tessa, Omvig Karen, Peipert Jeffrey F

机构信息

Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, Brazil; Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO.

Division of Family Planning, Department of Obstetrics and Gynecology, Washington University in St. Louis School of Medicine, St. Louis, MO.

出版信息

Contraception. 2017 Apr;95(4):382-389. doi: 10.1016/j.contraception.2016.12.006. Epub 2016 Dec 30.

Abstract

OBJECTIVE

Users of hormonal long-acting reversible contraception (LARC) report weight gain as a side effect, but few studies have assessed body composition change among LARC users. We evaluated weight and body composition of healthy women using the levonorgestrel intrauterine system (LNG-IUS), copper intrauterine device (copper IUD) or etonogestrel implant (ENG implant). We hypothesized that weight gain and body composition over 12 months would not differ between copper IUD, LNG-IUS and ENG implant users.

STUDY DESIGN

We performed a prospective cohort study of a subgroup of women enrolled in the Contraceptive CHOICE Project who initiated the LNG-IUS, copper IUD or ENG implant. Inclusion criteria included lack of metabolic and eating disorders or change in body weight of more than 5% in the 6 months before enrollment. We measured changes in weight and body composition (body fat percentage, total body fat mass, total lean mass and total body mass) in women who continued their method for 12 months.

RESULTS

We analyzed data from 149 participants: 85 LNG-IUS users, 31 copper IUD users and 33 ENG implant users. The mean age was 25.9 years, 56.4% were White, 82.5% had some college education and 67.6% were nulliparous. Although lean body mass increased over 12 months in LNG-IUS and copper IUD users but not in ENG implant users, changes in body weight and body composition did not differ between the groups. In the adjusted model, Black race was associated with change in total body mass (p<.05).

CONCLUSIONS

Among those who continued the method for 12 months, changes in body weight and composition did not differ between copper IUD, LNG-IUS and ENG implant users.

IMPLICATIONS STATEMENT

Changes in body weight and composition over 12 months did not differ between copper IUD users and LNG-IUS and ENG implant users among those with 12 months of continuous use.

摘要

目的

长效可逆激素避孕法(LARC)的使用者称体重增加是一种副作用,但很少有研究评估LARC使用者的身体成分变化。我们评估了使用左炔诺孕酮宫内节育系统(LNG-IUS)、铜宫内节育器(铜IUD)或依托孕烯植入剂(ENG植入剂)的健康女性的体重和身体成分。我们假设,在12个月内,铜IUD、LNG-IUS和ENG植入剂使用者的体重增加和身体成分变化没有差异。

研究设计

我们对参与避孕选择项目并开始使用LNG-IUS、铜IUD或ENG植入剂的女性亚组进行了一项前瞻性队列研究。纳入标准包括在入组前6个月内没有代谢和饮食紊乱或体重变化超过5%。我们测量了持续使用该方法12个月的女性的体重和身体成分变化(体脂百分比、全身脂肪量、总瘦体重和总体重)。

结果

我们分析了149名参与者的数据:85名LNG-IUS使用者、31名铜IUD使用者和33名ENG植入剂使用者。平均年龄为25.9岁,56.4%为白人,82.5%接受过一些大学教育,67.6%为未生育女性。尽管LNG-IUS和铜IUD使用者的瘦体重在12个月内有所增加,但ENG植入剂使用者没有增加,但各组之间的体重和身体成分变化没有差异。在调整模型中,黑人种族与总体重变化相关(p<0.05)。

结论

在持续使用该方法12个月的人群中,铜IUD、LNG-IUS和ENG植入剂使用者的体重和身体成分变化没有差异。

意义声明

在持续使用12个月的人群中,铜IUD使用者与LNG-IUS和ENG植入剂使用者在12个月内的体重和身体成分变化没有差异。

相似文献

1
Changes in body composition in women using long-acting reversible contraception.
Contraception. 2017 Apr;95(4):382-389. doi: 10.1016/j.contraception.2016.12.006. Epub 2016 Dec 30.
3
Weight change at 12 months in users of three progestin-only contraceptive methods.
Contraception. 2013 Oct;88(4):503-8. doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.
5
Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Contraception. 2012 Oct;86(4):350-3. doi: 10.1016/j.contraception.2012.01.017. Epub 2012 Mar 23.
8
Female sexual function in women using LARC methods.
Gynecol Endocrinol. 2022 Jan;38(1):68-72. doi: 10.1080/09513590.2021.1993813. Epub 2021 Oct 21.
9
[Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil].
Rev Assoc Med Bras (1992). 2006 Jan-Feb;52(1):32-6. doi: 10.1590/s0104-42302006000100019. Epub 2006 Apr 10.
10
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Fertil Steril. 2016 Jul;106(1):151-157.e5. doi: 10.1016/j.fertnstert.2016.02.036. Epub 2016 Mar 24.

引用本文的文献

1
Perceptions of women and their partners on postabortion intrauterine contraception: A qualitative study in central Uganda.
PLoS One. 2025 Jun 25;20(6):e0316982. doi: 10.1371/journal.pone.0316982. eCollection 2025.
2
Reproductive Planning and the Choice of Long-acting Reversible Contraceptive Primary to Health: A Cross-Sectional Study.
Rev Bras Ginecol Obstet. 2023 Aug;45(8):e456-e464. doi: 10.1055/s-0043-1772188. Epub 2023 Sep 8.
6
Contraceptive Options Following Gestational Diabetes: Current Perspectives.
Open Access J Contracept. 2019 Oct 22;10:41-53. doi: 10.2147/OAJC.S184821. eCollection 2019.
7
Assessing Weight Status in Adolescent and Young Adult Users of the Etonogestrel Contraceptive Implant.
J Pediatr Adolesc Gynecol. 2019 Aug;32(4):409-414. doi: 10.1016/j.jpag.2019.03.008. Epub 2019 Mar 27.

本文引用的文献

1
Update on long-acting reversible methods.
Curr Opin Obstet Gynecol. 2015 Dec;27(6):471-5. doi: 10.1097/GCO.0000000000000227.
2
Body composition and bone mineral density in users of the etonogestrel-releasing contraceptive implant.
Arch Gynecol Obstet. 2015 Dec;292(6):1387-91. doi: 10.1007/s00404-015-3784-0. Epub 2015 Jun 19.
3
Body composition and weight gain in new users of the three-monthly injectable contraceptive, depot-medroxyprogesterone acetate, after 12 months of follow-up.
Eur J Contracept Reprod Health Care. 2014 Dec;19(6):432-8. doi: 10.3109/13625187.2014.936934. Epub 2014 Jul 22.
5
Progestin-only contraceptives: effects on weight.
Cochrane Database Syst Rev. 2013 Jul 2;7(7):CD008815. doi: 10.1002/14651858.CD008815.pub3.
6
Weight change at 12 months in users of three progestin-only contraceptive methods.
Contraception. 2013 Oct;88(4):503-8. doi: 10.1016/j.contraception.2013.03.004. Epub 2013 Mar 18.
7
Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate.
Am J Obstet Gynecol. 2013 Jan;208(1):48.e1-8. doi: 10.1016/j.ajog.2012.10.876. Epub 2012 Oct 24.
8
Structured contraceptive counseling provided by the Contraceptive CHOICE Project.
Contraception. 2013 Aug;88(2):243-9. doi: 10.1016/j.contraception.2012.07.015. Epub 2012 Sep 5.
9
Effectiveness of long-acting reversible contraception.
N Engl J Med. 2012 May 24;366(21):1998-2007. doi: 10.1056/NEJMoa1110855.
10
Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Contraception. 2012 Oct;86(4):350-3. doi: 10.1016/j.contraception.2012.01.017. Epub 2012 Mar 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验